Melanoma: new treatments and hopes
September 19, 2011Research and Development advanced melanoma, melanoma, skin cancer
It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …
Eliquis launched in the UK
September 19, 2011Sales and Marketing Eliquis, Pradaxa, VTE, Xarelto
Eliquis, the latest entrant to the competitive oral anticoagulant market, has been launched in the UK.Co-developed and co-marketed by Pfizer …
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
UK-funded science research must be made more accessible, says minister
September 16, 2011Medical Communications, Research and Development UK science
Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …
Positive results for phase II malaria vaccine
September 16, 2011Research and Development malaria, malaria vaccine
Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …
Edelman appoints new head of digital health
September 16, 2011Medical Communications appointment, medical communications
Edelman has appointed Dave Pinnington as head of digital health for Europe to lead the development of the PR firm’s …
Firstlight launches new health offering
September 16, 2011Medical Communications Firstlight, medical communications news
London-based PR agency Firstlight has set up a new healthcare arm and appointed Pat Pearson to lead it. He is …
Merck’s COPD drug rejected by NICE
September 15, 2011Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast
NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …
Designing clinical trials for the real world
September 15, 2011Research and Development clinical trials
A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …
Almirall promotes Alfredo Barón
September 15, 2011Sales and Marketing appointment, sales and marketing
Spanish pharma company Almirall has promoted Alfredo Barón to area director for Southern and Eastern Europe. He has been with the …
Fresh scrutiny for new diabetes drugs
September 15, 2011Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes
Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …
Daiichi Sankyo subsidiary gets FDA warning
September 15, 2011Daiichi Sankyo, FDA, Luitpold
Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …
Digital Pharma: Lilly plans social media expansion
September 14, 2011Medical Communications Digital Pharma blog, Facebook, lilly, social media, youtube
One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …
First Paediatric Use Marketing Authorisation Granted
September 14, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …
GSK-Merck back new developing world cancer charity
September 14, 2011Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer
GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …
Merck collaborates with China-based genomics specialist BGI
September 14, 2011Research and Development BGI, Merck & Co, biomarkers, genomics
Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …
FDA unveils changes to cancer drug review
September 14, 2011Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs
The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …
GSK-Amicus start late-stage trials of Fabry disease treatment
September 14, 2011Research and Development Amicus Therapeutics, Fabry disease, GSK
GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …
Novartis loses global development head to Gates Foundation
September 14, 2011Research and Development Bill and Melinda Gates Foundation, Novartis, appointment
Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …
Government bites the bullet over A&E closure
September 14, 2011NHS, NHS reform, hosptials
The government has backed the closure of the Accident and Emergency department at Chase Farm hospital in London, ending years …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
